Add to ORKGPricing, reimbursements and coverage decisions for medical innovations and services are complex. In many countries, valuing medical technologies is the responsibility of national health-care systems that strive for distributive efficiency under fiscal constraints on medical spending. In the UK, the National Institute for Health and Clinical Excellence (NICE) is charged with the difficult task of assessing ne
Rising health care costs are an international concern, particularly in the United States, where spen...
Objectives: Our study explores whether, and how, different methodological choices are associated wit...
In this article, we review the development of health technology assessment (HTA) in England and Wale...
THE INTERPLAY AMONG QUALITYof care, technological innova-tion, and cost control creates apolicy chal...
Since the late 1970s, many European countries have established health technology assessment (HTA) sy...
The National Institute for Clinical Excellence (NICE) responds to requests by the Department of Heal...
This chapter reviews some of the concerns raised against the use of economic evaluation in the decis...
Sorenson Since the late 1970s, many European coun-tries have established health technology assessmen...
New technologies, including pharmaceuticals and medical devices, can improve treatment options in he...
Providing universal access to innovative, high-cost technologies leads to tensions in today’s healt...
Health technology assessment (HTA) has a long history in the United Kingdom. The first study underta...
Health Technology Assessment (HTA) is a multidisciplinary activity that acts as a "bridge" between e...
Member states have consistently limited the European Union’s competences in the area of healthcare r...
The economic evaluation which supports Health Technology Assessment (HTA) should inform policy maker...
The National Institute for Clinical Excellence (NICE) was set up as a special health authority for E...
Rising health care costs are an international concern, particularly in the United States, where spen...
Objectives: Our study explores whether, and how, different methodological choices are associated wit...
In this article, we review the development of health technology assessment (HTA) in England and Wale...
THE INTERPLAY AMONG QUALITYof care, technological innova-tion, and cost control creates apolicy chal...
Since the late 1970s, many European countries have established health technology assessment (HTA) sy...
The National Institute for Clinical Excellence (NICE) responds to requests by the Department of Heal...
This chapter reviews some of the concerns raised against the use of economic evaluation in the decis...
Sorenson Since the late 1970s, many European coun-tries have established health technology assessmen...
New technologies, including pharmaceuticals and medical devices, can improve treatment options in he...
Providing universal access to innovative, high-cost technologies leads to tensions in today’s healt...
Health technology assessment (HTA) has a long history in the United Kingdom. The first study underta...
Health Technology Assessment (HTA) is a multidisciplinary activity that acts as a "bridge" between e...
Member states have consistently limited the European Union’s competences in the area of healthcare r...
The economic evaluation which supports Health Technology Assessment (HTA) should inform policy maker...
The National Institute for Clinical Excellence (NICE) was set up as a special health authority for E...
Rising health care costs are an international concern, particularly in the United States, where spen...
Objectives: Our study explores whether, and how, different methodological choices are associated wit...
In this article, we review the development of health technology assessment (HTA) in England and Wale...